GlaxoSmithKline Pharmaceuticals logo

GlaxoSmithKline Pharmaceuticals share news, announcements and annual reports

NSE: GLAXOBSE: 500660Pharmaceuticals & BiotechnologyMid Cap

GlaxoSmithKline Pharmaceuticals Limited · Formerly Glaxo (India) · Face value ₹10 · Listed Jan 1969 on BSE, Dec 2000 on NSE
Last close ₹2,494.30down ₹20.80 (0.83%)BSE ₹2,483.55

Share price at the NSE close on 30 Oct 2026. Previous close ₹2,515.10.

30 Oct: open ₹2,527.60, high ₹2,528.90, low ₹2,479.30

52-week range of traded prices to 30 Oct 2026
₹2,088.10Low, 12 Jun 2026₹3,120.70High, 28 Aug 2026
Market cap
₹42,255 Cr221st largest listed
P/E
39.56
P/B
18.64
Dividend yield
2.29%
ROE
50.6%
ROCE
56.3%
Debt to equity
0.00
Volume, NSE
56,34965.0% delivered

GlaxoSmithKline Pharmaceuticals orders, deals and press releases

53 filed, newest first. Page 2 of 2.

  1. Nov 2013

  2. May 2008

    • 14 May · Business

      Press release dated May 14, 2008, titled "GSK Pharma signs co-promotion agreement with Daiichi Sankyo for anti-hypertensive drug". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 5 May · Business

      Press release dated May 05, 2008, titled "GSK Pharma signs licensing agreement with Astellas of Japan". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.